Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Report Id

46807

Publisher Name

Global Info Research

Published Date

2/22/2019

No of Pages

136

Market Scenario

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect. Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer. Scope of the Report: According to the research, the most potential market in the main countries of circulating tumor cells (CTCs) and cancer stem cells (CSCs) industry is China, determined by the rising level of medical care. Besides, South America, Asia-Pacific should also be focused by the investors. They are the potential consumers of circulating tumor cells (CTCs) and cancer stem cells (CSCs). The CellSearch test is the only FDA-approved test for CTC assessment. For the moment, the products are not comprehensive, and technologies are not stable. Morbidity and mortality rate of cancer is rising at a faster speed worldwide and thus prevention of cancer and cancer treatment is grabbing attention of cancer researchers globally. Stem cells and cell therapy have shown significant potential to treat cancer effectively. The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is valued at 6420 million USD in 2018 and is expected to reach 21700 million USD by the end of 2024, growing at a CAGR of 22.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs). Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%. This report studies the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by product type and applications/end industries. Market Segment by Companies, this report covers Janssen Qiagen Advanced Cell Diagnostics ApoCell Biofluidica Clearbridge Biomedics CytoTrack Celsee Fluxion Gilupi Cynvenio On-chip YZY Bio BioView Fluidigm Ikonisys AdnaGen IVDiagnostics Miltenyi Biotec ScreenCell Silicon Biosystems Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers CellSearch Others Market Segment by Applications, can be divided into Breast Cancer Diagnosis and Treatment Prostate Cancer Diagnosis and Treatment Colorectal Cancer Diagnosis and Treatment Lung Cancer Diagnosis and Treatment Other Cancers Diagnosis and Treatment

Table of Contents

Table of Contents 1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview 1.1 Product Overview and Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 1.2 Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Types 1.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Comparison by Types (2019-2024) 1.2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Types in 2018 1.2.3 CellSearch 1.2.4 Others 1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Application 1.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Breast Cancer Diagnosis and Treatment 1.3.3 Prostate Cancer Diagnosis and Treatment 1.3.4 Colorectal Cancer Diagnosis and Treatment 1.3.5 Lung Cancer Diagnosis and Treatment 1.3.6 Other Cancers Diagnosis and Treatment 1.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Regions 1.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Status and Prospect (2014-2024) 1.5 Global Market Size of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (2014-2024) 2 Manufacturers Profiles 2.1 Janssen 2.1.1 Business Overview 2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.2 Qiagen 2.2.1 Business Overview 2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.3 Advanced Cell Diagnostics 2.3.1 Business Overview 2.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.4 ApoCell 2.4.1 Business Overview 2.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.5 Biofluidica 2.5.1 Business Overview 2.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.6 Clearbridge Biomedics 2.6.1 Business Overview 2.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.7 CytoTrack 2.7.1 Business Overview 2.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.8 Celsee 2.8.1 Business Overview 2.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.9 Fluxion 2.9.1 Business Overview 2.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.10 Gilupi 2.10.1 Business Overview 2.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.11 Cynvenio 2.11.1 Business Overview 2.11.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.12 On-chip 2.12.1 Business Overview 2.12.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.13 YZY Bio 2.13.1 Business Overview 2.13.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.14 BioView 2.14.1 Business Overview 2.14.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.15 Fluidigm 2.15.1 Business Overview 2.15.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.16 Ikonisys 2.16.1 Business Overview 2.16.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.17 AdnaGen 2.17.1 Business Overview 2.17.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.18 IVDiagnostics 2.18.1 Business Overview 2.18.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.19 Miltenyi Biotec 2.19.1 Business Overview 2.19.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.20 ScreenCell 2.20.1 Business Overview 2.20.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 2.21 Silicon Biosystems 2.21.1 Business Overview 2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Gross Margin and Market Share (2017-2018) 3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Competition, by Players 3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share 3.2.2 Top 10 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share 3.3 Market Competition Trend 4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions 4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Regions 4.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 4.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 4.5 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 5 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries 5.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2014-2019) 5.2 USA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 5.3 Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 5.4 Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 6 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries 6.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2014-2019) 6.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 6.3 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 6.4 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 6.5 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 6.6 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries 7.1 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2014-2019) 7.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 7.3 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 7.4 Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 7.5 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 8 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries 8.1 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2014-2019) 8.2 Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 8.3 Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 8.4 Colombia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Countries 9.1 Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Countries (2014-2019) 9.2 Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 9.3 UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 9.4 Egypt Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 9.5 Nigeria Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 9.6 South Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2014-2019) 10 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment by Type 10.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2014-2019) 10.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Type (2019-2024) 10.3 CellSearch Revenue Growth Rate (2014-2024) 10.4 Others Revenue Growth Rate (2014-2024) 11 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Segment by Application 11.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2014-2019) 11.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Application (2019-2024) 11.3 Breast Cancer Diagnosis and Treatment Revenue Growth (2014-2019) 11.4 Prostate Cancer Diagnosis and Treatment Revenue Growth (2014-2019) 11.5 Colorectal Cancer Diagnosis and Treatment Revenue Growth (2014-2019) 11.6 Lung Cancer Diagnosis and Treatment Revenue Growth (2014-2019) 11.7 Other Cancers Diagnosis and Treatment Revenue Growth (2014-2019) 12 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2019-2024) 12.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast (2019-2024) 12.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast by Regions (2019-2024) 12.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2019-2024) 12.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2019-2024) 12.6 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now